MUC2 and inflammatory bowel disease: In IBD patients, reduced levels or absence of Muc2 gene expression and reduced Muc2 production and secretion lead to a thinner mucus layer, epithelial cell damage, increased intestinal permeability, and enhanced susceptibility to luminal toxins within the gut [71].